Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Non Operating Interest Expenses (2010 - 2026)

Palatin Technologies' (PTN) quarterly Non Operating Interest Expenses came in at $1268.0 in Q1 2026, down 29.36% on a YoY basis from $1795.0 in Q1 2025, and up 154.62% quarter-over-quarter from $498.0 in Q4 2025.

Analysis

Palatin Technologies (PTN) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Non Operating Interest Expenses for 16 consecutive years, with $1268.0 the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Interest Expenses fell 29.36% year-over-year to $1268.0; the trailing twelve-month figure through Mar 2026 stood at $7255.0 (down 37.12% YoY), and the FY2025 full-year result was $15025.0, down 97.84% from the prior year.
  • Non Operating Interest Expenses climbed to $1268.0 in Q1 2026 per PTN's latest filing, from $498.0 in the prior quarter.
  • Across five years, Non Operating Interest Expenses topped out at $1.1 million in Q4 2022 and bottomed at $498.0 in Q4 2025.
  • Historically, Non Operating Interest Expenses has averaged $125194.7 across 5 years, with a median of $3487.0 in 2025.
  • The sharpest annual moves came in 2022 and 2024: Non Operating Interest Expenses surged 40136.75% in 2022, then plunged 99.45% in 2024.
  • Over 5 years, Non Operating Interest Expenses stood at $1.1 million in 2022, then slumped by 37.54% to $696912.0 in 2023, then slumped by 99.45% to $3803.0 in 2024, then sank by 86.91% to $498.0 in 2025, then surged by 154.62% to $1268.0 in 2026.
  • According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $1268.0, $498.0, and $2002.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 673.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 247.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 11.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -1.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 82.05 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Palatin Technologies 46.98 Mn 46.98 Mn - 1,268.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1,268.00
Dec 31, 2025 498.00
Sep 30, 2025 2,002.00
Jun 30, 2025 3,487.00
Mar 31, 2025 1,795.00
Dec 31, 2024 3,803.00
Sep 30, 2024 5,940.00
Mar 31, 2024 1,254.00
Dec 31, 2023 696,912.00
Sep 30, 2023 10,882.00
Mar 31, 2023 3,434.00
Dec 31, 2022 1.12 Mn
Sep 30, 2022 9,602.00
Jun 30, 2022 18,259.00
Mar 31, 2022 3,019.00
Dec 31, 2021 2,773.00
Sep 30, 2021 5,631.00
Jun 30, 2021 14,080.00
Dec 31, 2020 1,871.00
Sep 30, 2020 7,489.00